The iLet Bionic Pancreas from Beta Bionics offers a groundbreaking approach to insulin therapy. Unlike traditional automated insulin delivery (AID) systems, the iLet Insulin Pump doesn’t require users to enter carb counts or manually adjust insulin settings. Instead, it relies on a built-in algorithm that work together to handle basal insulin, correction doses, and meal-related insulin delivery—all automatically.

This makes the iLet ideal for people who want to reduce the burden of constant decision-making in diabetes management. Users simply announce whether a meal is small, medium, or large—and the system takes it from there. Even if a meal is forgotten or misjudged, the iLet’s correction algorithm can respond to rising glucose levels in real time.

What makes the iLet even more user-friendly is its simplified onboarding: the only setting needed to get started is the user’s body weight. The system is designed to learn over time, adjusting doses based on individual needs and patterns. Users can also select from three glucose target ranges—110, 120, or 130 mg/dL.

Bonus sneak peek: Beta Bionics is also working on a new tubeless insulin pump called Mint—and I got to see it in person at ADA 2025 in Chicago. This exciting new device could be a game-changer for those looking for a more discreet, wearable option. Stay tuned for more on this innovation!

For the latest diabetes tech, join our newsletter. And if you’re enjoying our content, consider joining Diabetech All Access—our premium membership with exclusive stories and in-depth industry analysis. Your support helps sustain our independent journalism and keeps this platform thriving.

Diabetech content is not medical advice—and are for educational purposes only. Always consult with a physician before making changes to your healthcare.